Partner Olivier Beaudouin interviewed by IFR on Bryan Garnier’s leadership in the Energy Transition and Sustainability sector
International Financing Review (IFR) has written a piece highlighting Bryan Garnier’s leadership in the Energy Transition and Sustainability sector. From insect protein to hydrogen, the piece highlights some of the landmark transactions that Bryan Garnier has advised on and the sector knowledge that our bankers leverage to ensure the best outcome for disruptive sustainability companies and their investors.
Olivier explains the unique financing structures that Bryan Garnier advises on that ensure that companies have the right combination of investors on board so that they can scale up.
The piece highlights Bryan Garnier’s position as the go-to bank for European disruptors and their investors. “We generally act as the lead adviser on transactions as we’ve been in this space for 15 years so we leverage our long-standing and extensive relationships with the strategic and private and public financial ecosystem globally very well, while keeping the agility of an entrepreneurial firm,” Beaudouin said.
Read the full article here:
For more information, please contact Olivier Beaudouin
Olivier Beaudouin
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.